Cargando…
COVID-19 vaccine effectiveness in adults with developmental disabilities living in group homes
Autores principales: | Hirsch, K.M., Reidenberg, B.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society for Public Health. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119960/ https://www.ncbi.nlm.nih.gov/pubmed/35718555 http://dx.doi.org/10.1016/j.puhe.2022.05.006 |
Ejemplares similares
-
Drive through COVID19 vaccination for developmentally disabled persons
por: Reidenberg, Bruce E., et al.
Publicado: (2022) -
Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023) -
Author's reply. “Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment”
por: Meijide Míguez, Héctor, et al.
Publicado: (2023) -
COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State
por: Landes, Scott D., et al.
Publicado: (2020) -
Prescription cascading in developmentally disabled individuals
por: Patel, Isha, et al.
Publicado: (2016)